NM_004304.5:c.2759G>T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PP3_ModerateBP6_Moderate

The NM_004304.5(ALK):​c.2759G>T​(p.Gly920Val) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely benign (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G920S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000030 ( 0 hom., cov: 23)
Exomes 𝑓: 0.00024 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

ALK
NM_004304.5 missense

Scores

11
6
2

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 7.35

Publications

2 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
ALK Gene-Disease associations (from GenCC):
  • neuroblastoma, susceptibility to, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.893
BP6
Variant 2-29228940-C-A is Benign according to our data. Variant chr2-29228940-C-A is described in ClinVar as Likely_benign. ClinVar VariationId is 3524397.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALKNM_004304.5 linkc.2759G>T p.Gly920Val missense_variant Exon 16 of 29 ENST00000389048.8 NP_004295.2
ALKXR_001738688.3 linkn.3668+18G>T intron_variant Intron 16 of 17

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALKENST00000389048.8 linkc.2759G>T p.Gly920Val missense_variant Exon 16 of 29 1 NM_004304.5 ENSP00000373700.3
ALKENST00000618119.4 linkc.1628G>T p.Gly543Val missense_variant Exon 15 of 28 5 ENSP00000482733.1

Frequencies

GnomAD3 genomes
AF:
0.0000305
AC:
3
AN:
98516
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000116
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000187
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000781
GnomAD2 exomes
AF:
0.0000451
AC:
11
AN:
243688
AF XY:
0.0000606
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000893
Gnomad ASJ exome
AF:
0.000102
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000182
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000236
AC:
175
AN:
741622
Hom.:
0
Cov.:
22
AF XY:
0.000253
AC XY:
95
AN XY:
375390
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000114
AC:
2
AN:
17568
American (AMR)
AF:
0.000496
AC:
13
AN:
26232
Ashkenazi Jewish (ASJ)
AF:
0.000130
AC:
2
AN:
15412
East Asian (EAS)
AF:
0.000493
AC:
12
AN:
24358
South Asian (SAS)
AF:
0.000708
AC:
37
AN:
52294
European-Finnish (FIN)
AF:
0.000253
AC:
9
AN:
35524
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3696
European-Non Finnish (NFE)
AF:
0.000174
AC:
93
AN:
535698
Other (OTH)
AF:
0.000227
AC:
7
AN:
30840
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.256
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000304
AC:
3
AN:
98534
Hom.:
0
Cov.:
23
AF XY:
0.0000418
AC XY:
2
AN XY:
47882
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
26098
American (AMR)
AF:
0.000116
AC:
1
AN:
8634
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2428
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3474
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3160
European-Finnish (FIN)
AF:
0.000187
AC:
1
AN:
5356
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
220
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
47192
Other (OTH)
AF:
0.000774
AC:
1
AN:
1292
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.258
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000313
Hom.:
0

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Benign:1
Aug 21, 2024
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.98
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Pathogenic
29
DANN
Uncertain
1.0
DEOGEN2
Benign
0.40
T;.
Eigen
Pathogenic
0.86
Eigen_PC
Pathogenic
0.80
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Uncertain
0.96
D;D
M_CAP
Pathogenic
0.42
D
MetaRNN
Pathogenic
0.89
D;D
MetaSVM
Uncertain
0.44
D
MutationAssessor
Pathogenic
3.7
H;.
PhyloP100
7.4
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-6.3
D;.
REVEL
Pathogenic
0.67
Sift
Uncertain
0.0050
D;.
Sift4G
Pathogenic
0.0
D;D
Polyphen
1.0
D;.
Vest4
0.87
MutPred
0.58
Loss of disorder (P = 0.0177);.;
MVP
0.73
MPC
0.79
ClinPred
0.87
D
GERP RS
5.2
Varity_R
0.79
gMVP
0.90
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746643773; hg19: chr2-29451806; API